Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Oral Medicine / General Medicine

Derm Cases · Dermatology / Oral Medicine / General Medicine

OSCE — assessment of cutaneous and mucosal lichen planus with hepatitis C screening

An 8-minute OSCE station assessing recognition of the 6 Ps and Wickham striae, oral/nail/scalp examination, hepatitis C association, and stepwise management of cutaneous and oral lichen planus per European guidance.

8 minosce2 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station assessing recognition of the 6 Ps and Wickham striae, oral/nail/scalp examination, hepatitis C association, and stepwise management of cutaneous and oral lichen planus per European guidance.

Brief (to candidate)

A 48-year-old man has intensely itchy, flat-topped violaceous papules on the flexor wrists and shins for 4 months, white lacy streaks in the buccal mucosa, and recent longitudinal nail ridging with one pterygium. You have 8 minutes to confirm the diagnosis, examine all key sites, screen associations, and outline management.

Candidate instructions

  1. Describe classic cutaneous morphology (the 6 Ps) and Wickham striae.
  2. Examine/state need to examine oral cavity, nails, scalp/genital mucosa.
  3. Discuss hepatitis C screening rationale and other associations (drugs, dental amalgam debate for oral disease).
  4. Outline topical and systemic treatment by site and severity.
  5. Counsel on chronicity, malignant risk in chronic erosive oral LP, and follow-up.
[8]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
RecognitionPruritic, purple, polygonal, planar, papules/plaques (6 Ps) ± Wickham striae; flexor wrists, shins, sacral area classic; Koebner phenomenon may be noted[2]
Site surveyOral (reticular Wickham network, erosive forms), nails (thinning, ridging, pterygium, anonychia risk), scalp (lichen planopilaris → scarring alopecia), genitalia if indicated[5]
AssociationsScreens for HCV (especially oral LP / endemic regions); drug-induced lichenoid eruptions; autoimmune thyroid disease sometimes coexists; biopsy if atypical[7]
Cutaneous RxPotent/superpotent topical corticosteroids first-line; occlusion for hypertrophic LP; phototherapy or systemic (e.g. oral corticosteroids short course, other immunosuppressants) for extensive disease per guidelines[1]
Oral / nail RxOral: topical corticosteroid gels/pastes or TCI; dental review; systemic therapy for severe erosive disease; nail LP needs early aggressive therapy to prevent irreversible dystrophy[1][5]
Safety & malignancyChronic erosive oral LP → monitor for SCC; stop culprit drugs if lichenoid drug eruption; explain itch control and pigmented sequelae (PIH)
CommunicationSets expectations (months course; post-inflammatory hyperpigmentation common in skin of colour); clear review plan

Model key actions

  • Diagnose classic cutaneous LP with oral and nail involvement; name Wickham striae and the 6 Ps.[2]
  • Order HCV serology when appropriate; examine all mucosae/nails/scalp.[7]
  • Start potent topical steroids for skin; site-specific oral/nail plans; escalate per European S1 guidance if extensive/erosive.[1]

Common errors

  • Examining only skin and missing oral / nail / scarring scalp disease.
  • Omitting HCV consideration in oral LP.
  • Under-treating nail LP until permanent dystrophy.
  • Ignoring erosive oral LP cancer surveillance.
  • Misdiagnosing as psoriasis without noting violaceous flat-topped morphology and mucosal findings.
[1] [5] [7]
References5ShowHide
  1. [1]Ioannides D, Vakirlis E, Kemeny L, et al. European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology and Venereology, 2020.PMID 32678513
  2. [2]Le Cleach L, Chosidow O. Clinical practice. Lichen planus. New England Journal of Medicine, 2012.PMID 22356325
  3. [5]Gupta MK, Lipner SR. Review of Nail Lichen Planus: Epidemiology, Pathogenesis, Diagnosis, and Treatment. Dermatologic Clinics, 2021.PMID 33745635
  4. [7]García-Pola M, Rodríguez-Fonseca L, Suárez-Fernández C, et al. Bidirectional Association between Lichen Planus and Hepatitis C-An Update Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 2023.PMID 37762719
  5. [8]Atzmony L, Reiter O, Hodak E, Gdalevich M, Mimouni D. Treatments for Cutaneous Lichen Planus: A Systematic Review and Meta-Analysis Am J Clin Dermatol, 2016.PMID 26507510
PreviousOSCE — assessment of papulopustular rosacea with ocular symptomsDermatology / General MedicineNextOSCE — assessment of facial and scalp seborrhoeic dermatitis with red-flag severityDermatology / General Medicine / Infectious Disease interface